Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus.

Cite this paper

@article{Qi2014PreclinicalPA, title={Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus.}, author={Yanxin Qi and Huanhuan Guo and Ningning Hu and Dongyun He and Shi Chuan Zhang and Yunjie Chu and Yubin Huang and Xiao Li and Lili Sun and Ningyi Jin}, journal={Toxicology and applied pharmacology}, year={2014}, volume={280 2}, pages={362-9} }